Literature DB >> 27839960

Phase 1/2 study of blinatumomab in relapsed paediatric ALL.

Vicki Brower.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27839960     DOI： 10.1016/S1470-2045(16)30580-0

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  1 in total

1.  Immunotherapy- (Blinatumomab-) Related Lineage Switch of KMT2A/AFF1 Rearranged B-Lymphoblastic Leukemia into Acute Myeloid Leukemia/Myeloid Sarcoma and Subsequently into B/Myeloid Mixed Phenotype Acute Leukemia.

Authors:  Rui R He; Zacharia Nayer; Matthew Hogan; Raymund S Cuevo; Kimberly Woodward; David Heyer; Christine A Curtis; Jess F Peterson
Journal:  Case Rep Hematol       Date:  2019-12-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.